Adempas Tablets and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose
Determining the interaction of Adempas Tablets and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Kisqali Femara Co-Pack 400 mg-2.5 mg Dose
- Adempas Tablets-Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
- Adempas Tablets-Kitabis Pak
- Adempas Tablets-Kitabis Pak inhalation
- Adempas Tablets-Klofensaid II
- Adempas Tablets-Klonopin
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Adenocard
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Adenoscan
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Adenosine
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Adenosine Intravenous
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Kisqali Femara Co-Pack 200 mg-2.5 mg Dose-Adenovirus Vaccine